PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Rikard Holmdahl Selected Research
Arthritis (Polyarthritis)
07/2008
Cartilage oligomeric matrix protein induction of chronic arthritis in mice.
01/2008
The role of collagen antibodies in mediating arthritis.
12/2007
The Rheumatoid Arthritis-Associated Autoantigen hnRNP-A2 (RA33) Is a Major Stimulator of Autoimmunity in Rats with Pristane-Induced Arthritis.
10/2007
Endoglycosidase treatment abrogates IgG arthritogenicity: importance of IgG glycosylation in arthritis.
10/2007
Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species.
08/2007
Lack of reactive oxygen species breaks T cell tolerance to collagen type II and allows development of arthritis in mice.
05/2007
Quantitative structure-activity relationship of peptides binding to the class II major histocompatibility complex molecule Aq associated with autoimmune arthritis.
02/2007
Type II collagen without adjuvant induces eosinophilic arthritis.
01/2007
Ethanol prevents development of destructive arthritis.
01/2007
Collagen antibody induced arthritis.
01/2007
Arthritis suppression by NADPH activation operates through an interferon-beta pathway.
01/2007
Arthritis induced with minor cartilage proteins.
01/2007
Pristane-induced arthritis in the rat.
02/2006
Therapeutic vaccination of active arthritis with a glycosylated collagen type II peptide in complex with MHC class II molecules.
01/2006
Type IX collagen deficiency enhances the binding of cartilage-specific antibodies and arthritis severity.
09/2005
Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis.
03/2005
The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis.
02/2005
The major T cell epitope on type II collagen is glycosylated in normal cartilage but modified by arthritis in both rats and humans.
01/2005
Induction of a B-cell-dependent chronic arthritis with glucose-6-phosphate isomerase.
07/2004
Antileukoproteinase: modulation of neutrophil function and therapeutic effects on anti-type II collagen antibody-induced arthritis.
01/2004
Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells.
12/2003
Chronicity of pristane-induced arthritis in rats is controlled by genes on chromosome 14.
11/2003
Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes.
10/2003
Genetic control of tolerance to type II collagen and development of arthritis in an autologous collagen-induced arthritis model.
08/2003
A comparative genetic analysis between collagen-induced arthritis and pristane-induced arthritis.
08/2003
Induction of arthritis by single monoclonal IgG anti-collagen type II antibodies and enhancement of arthritis in mice lacking inhibitory FcgammaRIIB.
07/2003
Identification and isolation of dominant susceptibility loci for pristane-induced arthritis.
01/2003
Differential gene expression in pristane-induced arthritis susceptible DA versus resistant E3 rats.
08/2002
Both common and unique susceptibility genes in different rat strains with pristane-induced arthritis.
05/2002
Immunization of rats with homologous type XI collagen leads to chronic and relapsing arthritis with different genetics and joint pathology than arthritis induced with homologous type II collagen.
Articles by Research Topic
Disease
30
Arthritis (Polyarthritis)
07/2008 - 05/2002
12
Rheumatoid Arthritis
12/2007 - 07/2002
12
Experimental Arthritis
11/2007 - 06/2002
2
Inflammation
04/2008 - 01/2008
2
Relapsing Polychondritis
03/2004 - 01/2004
2
Demyelinating Diseases (Demyelinating Disease)
03/2003 - 07/2002
2
Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2003 - 07/2002
1
Bronchitis
09/2008
1
Allergic Contact Dermatitis
08/2008
1
Autoimmune Diseases (Autoimmune Disease)
07/2008
1
Adult Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
04/2008
1
Lyme Disease (Disease, Lyme)
09/2005
Drug/Important Bio-Agent (IBA)
17
Collagen Type II (Type II Collagen)
IBA
01/2008 - 05/2002
8
Antibodies
IBA
01/2008 - 09/2002
7
pristane (pristan)
IBA
12/2007 - 08/2002
6
Collagen
IBA
08/2008 - 09/2003
4
Immunoglobulin G (IgG)
IBA
04/2008 - 08/2003
3
Reactive Oxygen Species (Oxygen Radicals)
IBA
10/2007 - 08/2007
2
Rheumatoid Factor
IBA
09/2008 - 12/2003
2
Peptides
IBA
08/2008 - 05/2007
2
cartilage matrix protein
IBA
07/2008 - 03/2004
2
Complement System Proteins (Complement)
IBA
01/2007 - 03/2004
2
NADP (NADPH)
IBA
01/2007 - 09/2005
2
Interferon-beta
IBA
01/2007 - 12/2005
2
glycosylated collagen
IBA
02/2006 - 07/2002
2
Epitopes
IBA
09/2005 - 01/2005
2
T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)
IBA
02/2005 - 06/2002
2
oligodendrocyte-myelin glycoprotein
IBA
01/2003 - 07/2002
1
interleukin-21 (interleukin 21)
IBA
07/2008
1
Toll-Like Receptor 4
IBA
04/2008
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
11/2007
1
Ethanol (Ethyl Alcohol)
IBA
01/2007
1
Proteins (Proteins, Gene)
IBA
01/2007
1
NADPH Oxidase (NAD(P)H oxidase)
IBA
01/2007
1
Collagen Type IX
IBA
01/2006
1
HLA-DRB1 antigen (HLA DRB1)
IBA
01/2006
1
Protein Tyrosine Phosphatases
IBA
01/2006
1
Monoclonal Antibodies
IBA
09/2005
1
Oxidoreductases
IBA
09/2005
1
Plasminogen
IBA
08/2005
1
Plasminogen Activators (Plasminogen Activator)
IBA
03/2005
1
Plasmin (Fibrinolysin)
FDA Link
03/2005
1
Perforin
IBA
01/2005
1
Glucose-6-Phosphate Isomerase (Phosphoglucose Isomerase)
IBA
01/2005
1
Interleukin-10 (Interleukin 10)
IBA
01/2004
1
Glycopeptides
IBA
09/2003
1
Osteopontin
IBA
03/2003
1
Collagen Type XI
IBA
05/2002
Therapy/Procedure
1
Transplantation (Transplant Recipients)
06/2002